Characteristics . | SIM (n = 337) . | EZ-SIM (n = 564) . | ATOR (n = 1510) . | P . |
---|---|---|---|---|
Age (y) | 67.3 ± 11.5 | 65.4 ± 10.9a | 66.2 ± 11.0 | .047 |
Age ≥75 years | 101 (30.0) | 120 (21.3)a | 373 (24.7) | .014 |
Sex | .870 | |||
Male | 192 (57.0) | 312 (55.3) | 838 (55.5) | |
Female | 145 (43.0) | 252 (44.7) | 672 (44.5) | |
Previous MI | 8 (2.4) | 15 (2.7) | 27 (1.8) | .425 |
Previous cerebral vascular accident | ||||
Anyc | 104 (30.9) | 130 (23.0)a | 344 (22.8)a | .006 |
Ischemic | 81 (24.0) | 104 (18.4) | 254 (16.8)a | .008 |
Hemorrhage | 10 (3.0) | 15 (2.7) | 38 (2.5) | .893 |
Unspecified | 48 (14.2) | 57 (10.1) | 152 (10.1) | .071 |
Comorbidity | ||||
Neuropathy | 64 (19.0) | 91 (16.1) | 155 (10.3)a,b | <.001 |
Retinopathy | 17 (5.0) | 32 (5.7) | 63 (4.2) | .328 |
CAD | 47 (13.9) | 68 (12.1) | 170 (11.3) | .377 |
Chronic kidney disease | 13 (3.9) | 15 (2.7) | 40 (2.6) | .464 |
Chronic obstructive pulmonary disease | 49 (14.5) | 57 (10.1) | 168 (11.1) | .114 |
AF | 22 (6.5) | 16 (2.8)a | 110 (7.3)b | .001 |
Peripheral arterial disease | 37 (11.0) | 46 (8.2) | 84 (5.6)a | .001 |
Hypertension | 304 (90.2) | 478 (84.8) | 1283 (85.0)a | .036 |
Heart failure | 26 (7.7) | 26 (4.6) | 102 (6.8) | .116 |
Malignancy | 13 (3.9) | 23 (4.1) | 68 (4.5) | .828 |
Cirrhosis | 5 (1.5) | 0 (0.0)a | 13 (0.9) | .031 |
Previous PCI | 2 (0.6) | 4 (0.7) | 16 (1.1) | .607 |
Previous carotid stenting | 0 (0.0) | 0 (0.0) | 2 (0.1) | .550 |
Characteristics . | SIM (n = 337) . | EZ-SIM (n = 564) . | ATOR (n = 1510) . | P . |
---|---|---|---|---|
Age (y) | 67.3 ± 11.5 | 65.4 ± 10.9a | 66.2 ± 11.0 | .047 |
Age ≥75 years | 101 (30.0) | 120 (21.3)a | 373 (24.7) | .014 |
Sex | .870 | |||
Male | 192 (57.0) | 312 (55.3) | 838 (55.5) | |
Female | 145 (43.0) | 252 (44.7) | 672 (44.5) | |
Previous MI | 8 (2.4) | 15 (2.7) | 27 (1.8) | .425 |
Previous cerebral vascular accident | ||||
Anyc | 104 (30.9) | 130 (23.0)a | 344 (22.8)a | .006 |
Ischemic | 81 (24.0) | 104 (18.4) | 254 (16.8)a | .008 |
Hemorrhage | 10 (3.0) | 15 (2.7) | 38 (2.5) | .893 |
Unspecified | 48 (14.2) | 57 (10.1) | 152 (10.1) | .071 |
Comorbidity | ||||
Neuropathy | 64 (19.0) | 91 (16.1) | 155 (10.3)a,b | <.001 |
Retinopathy | 17 (5.0) | 32 (5.7) | 63 (4.2) | .328 |
CAD | 47 (13.9) | 68 (12.1) | 170 (11.3) | .377 |
Chronic kidney disease | 13 (3.9) | 15 (2.7) | 40 (2.6) | .464 |
Chronic obstructive pulmonary disease | 49 (14.5) | 57 (10.1) | 168 (11.1) | .114 |
AF | 22 (6.5) | 16 (2.8)a | 110 (7.3)b | .001 |
Peripheral arterial disease | 37 (11.0) | 46 (8.2) | 84 (5.6)a | .001 |
Hypertension | 304 (90.2) | 478 (84.8) | 1283 (85.0)a | .036 |
Heart failure | 26 (7.7) | 26 (4.6) | 102 (6.8) | .116 |
Malignancy | 13 (3.9) | 23 (4.1) | 68 (4.5) | .828 |
Cirrhosis | 5 (1.5) | 0 (0.0)a | 13 (0.9) | .031 |
Previous PCI | 2 (0.6) | 4 (0.7) | 16 (1.1) | .607 |
Previous carotid stenting | 0 (0.0) | 0 (0.0) | 2 (0.1) | .550 |
Characteristics . | SIM (n = 337) . | EZ-SIM (n = 564) . | ATOR (n = 1510) . | P . |
---|---|---|---|---|
Age (y) | 67.3 ± 11.5 | 65.4 ± 10.9a | 66.2 ± 11.0 | .047 |
Age ≥75 years | 101 (30.0) | 120 (21.3)a | 373 (24.7) | .014 |
Sex | .870 | |||
Male | 192 (57.0) | 312 (55.3) | 838 (55.5) | |
Female | 145 (43.0) | 252 (44.7) | 672 (44.5) | |
Previous MI | 8 (2.4) | 15 (2.7) | 27 (1.8) | .425 |
Previous cerebral vascular accident | ||||
Anyc | 104 (30.9) | 130 (23.0)a | 344 (22.8)a | .006 |
Ischemic | 81 (24.0) | 104 (18.4) | 254 (16.8)a | .008 |
Hemorrhage | 10 (3.0) | 15 (2.7) | 38 (2.5) | .893 |
Unspecified | 48 (14.2) | 57 (10.1) | 152 (10.1) | .071 |
Comorbidity | ||||
Neuropathy | 64 (19.0) | 91 (16.1) | 155 (10.3)a,b | <.001 |
Retinopathy | 17 (5.0) | 32 (5.7) | 63 (4.2) | .328 |
CAD | 47 (13.9) | 68 (12.1) | 170 (11.3) | .377 |
Chronic kidney disease | 13 (3.9) | 15 (2.7) | 40 (2.6) | .464 |
Chronic obstructive pulmonary disease | 49 (14.5) | 57 (10.1) | 168 (11.1) | .114 |
AF | 22 (6.5) | 16 (2.8)a | 110 (7.3)b | .001 |
Peripheral arterial disease | 37 (11.0) | 46 (8.2) | 84 (5.6)a | .001 |
Hypertension | 304 (90.2) | 478 (84.8) | 1283 (85.0)a | .036 |
Heart failure | 26 (7.7) | 26 (4.6) | 102 (6.8) | .116 |
Malignancy | 13 (3.9) | 23 (4.1) | 68 (4.5) | .828 |
Cirrhosis | 5 (1.5) | 0 (0.0)a | 13 (0.9) | .031 |
Previous PCI | 2 (0.6) | 4 (0.7) | 16 (1.1) | .607 |
Previous carotid stenting | 0 (0.0) | 0 (0.0) | 2 (0.1) | .550 |
Characteristics . | SIM (n = 337) . | EZ-SIM (n = 564) . | ATOR (n = 1510) . | P . |
---|---|---|---|---|
Age (y) | 67.3 ± 11.5 | 65.4 ± 10.9a | 66.2 ± 11.0 | .047 |
Age ≥75 years | 101 (30.0) | 120 (21.3)a | 373 (24.7) | .014 |
Sex | .870 | |||
Male | 192 (57.0) | 312 (55.3) | 838 (55.5) | |
Female | 145 (43.0) | 252 (44.7) | 672 (44.5) | |
Previous MI | 8 (2.4) | 15 (2.7) | 27 (1.8) | .425 |
Previous cerebral vascular accident | ||||
Anyc | 104 (30.9) | 130 (23.0)a | 344 (22.8)a | .006 |
Ischemic | 81 (24.0) | 104 (18.4) | 254 (16.8)a | .008 |
Hemorrhage | 10 (3.0) | 15 (2.7) | 38 (2.5) | .893 |
Unspecified | 48 (14.2) | 57 (10.1) | 152 (10.1) | .071 |
Comorbidity | ||||
Neuropathy | 64 (19.0) | 91 (16.1) | 155 (10.3)a,b | <.001 |
Retinopathy | 17 (5.0) | 32 (5.7) | 63 (4.2) | .328 |
CAD | 47 (13.9) | 68 (12.1) | 170 (11.3) | .377 |
Chronic kidney disease | 13 (3.9) | 15 (2.7) | 40 (2.6) | .464 |
Chronic obstructive pulmonary disease | 49 (14.5) | 57 (10.1) | 168 (11.1) | .114 |
AF | 22 (6.5) | 16 (2.8)a | 110 (7.3)b | .001 |
Peripheral arterial disease | 37 (11.0) | 46 (8.2) | 84 (5.6)a | .001 |
Hypertension | 304 (90.2) | 478 (84.8) | 1283 (85.0)a | .036 |
Heart failure | 26 (7.7) | 26 (4.6) | 102 (6.8) | .116 |
Malignancy | 13 (3.9) | 23 (4.1) | 68 (4.5) | .828 |
Cirrhosis | 5 (1.5) | 0 (0.0)a | 13 (0.9) | .031 |
Previous PCI | 2 (0.6) | 4 (0.7) | 16 (1.1) | .607 |
Previous carotid stenting | 0 (0.0) | 0 (0.0) | 2 (0.1) | .550 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.